Related references
Note: Only part of the references are listed.Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain
Koray Ozduman et al.
JOURNAL OF NEUROSCIENCE (2008)
Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells
Matteo Di Piazza et al.
JOURNAL OF VIROLOGY (2007)
Effects of intravenously administered recombinant vesicular stomatitis virus (VSVΔM51) on Multifocal and invasive gliomas
XueQing Lun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Rejection of RG-2 gliomas is mediated by microglia and T lymphocytes
Christopher L. Mariani et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Serial passage through human glioma xenografts selects for a Δγ134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors
Amish C. Shah et al.
JOURNAL OF VIROLOGY (2006)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
Recent progress in the battle between oncolytic viruses and tumours
KA Parato et al.
NATURE REVIEWS CANCER (2005)
Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas
XQ Lun et al.
CANCER RESEARCH (2005)
An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor
H Kambara et al.
CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Replication-selective oncolytic viruses in the treatment of cancer
B Everts et al.
CANCER GENE THERAPY (2005)
Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing
MHY Calle et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases
Z Raykov et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restrict parvovirus H-1 in mouse cells
C Wrzesinski et al.
JOURNAL OF VIROLOGY (2003)
Reovirus as an oncolytic agent against experimental human malignant gliomas
ME Wilcox et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Intergeneric poliovirus recombinants for the treatment of malignant glioma
M Gromeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Cyclin A activates the DNA polymerase δ-dependent elongation machinery in vitro:: A parvoviuus DNA replication model
T Bashir et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)